Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 22, 2017
Pharmacy Choice - Pharmaceutical News - ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP) Files An 8-K Submission of Matters to a Vote of Security Holders - October 22, 2017

Pharmacy News Article

 5/19/17 - ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP) Files An 8-K Submission of Matters to a Vote of Security Holders

ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07.

Submission of Matters to a Vote of Security
Holders.

On May 17, 2017, ANI Pharmaceuticals, Inc. (the Company) held its
2017 Annual Meeting of Stockholders. The following matters, all
of which were set forth in the Company's proxy statement for the
2017 Annual Meeting (Annual Meeting), were voted on and approved
by the Company's stockholders. The voting results for each
proposal are set forth below.

1. The individuals listed below were elected at the Annual
Meeting to serve as directors of the Company until the next
annual meeting of shareholders and until their successors are
duly elected and qualified:

Nominee For Against Abstained BrokerNon-Votes
1. Robert E. Brown, Jr. 6,992,097 555,987 6,604 2,576,661
2. Arthur S. Przybyl 7,134,281 417,434 2,973 2,576,661
3. Fred Holubow 7,347,502 204,136 3,050 2,576,661
4. Tracy L. Marshbanks, Ph.D. 7,347,994 203,674 3,020 2,576,661
5. Thomas A. Penn 6,756,615 791,462 6,611 2,576,661
6. Daniel Raynor 6,886,364 665,501 2,823 2,576,661

2. The Companys Fifth Amended and Restated 2008 Stock Incentive
Plan was approved.

For Against Abstained Broker Non-Votes
7,340,037 204,903 9,748 2,576,661

3. The appointment of EisnerAmper LLP as the Company's
independent registered public accounting firm for the year ending
December 31, 2017 2017, as described in the proxy materials, was
approved.

For Against Abstained Broker Non-Votes
10,041,849 73,095 16,405

4. The executive compensation of the Company's named executive
officers, as described in the proxy materials, was approved.

For Against Abstained Broker Non-Votes
6,575,271 965,622 13,795 2,576,661

About ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP)
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company's focused areas of product development include anti-cancer (oncolytics), hormones and steroids, and complex formulations. Its generic products include Esterified Estrogen with Methyltestosterone, Etodolac, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup, Nimodipine, Opium Tincture, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Lithobid, Reglan and Vancocin. It has over two pharmaceutical manufacturing facilities located in Baudette, Minnesota that are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products. Its two facilities have a combined manufacturing, packaging and laboratory capacity totaling approximately 173,000 square feet. ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP) Recent Trading Information
ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP) closed its last trading session 00.00 at 47.89 with 126,184 shares trading hands.

The post ANI PHARMACEUTICALS, INC. (NASDAQ:ANIP) Files An 8-K Submission of Matters to a Vote of Security Holders appeared first on Market Exclusive.



© Market Exclusive 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Oct 23: Vitamin D Primer for Pharmacy Professionals
Oct 24: Metabolic Syndrome: The Heart of Any Wellness Practice
Oct 25: Dispensing Controlled Substances in Today’s Pharmacy
Oct 26: Management of Schizophrenia & Acute Agitation
Oct 27: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415